Pranlukast - CISMeF

Preferred Label : Pranlukast;

NCIt synonyms : N-(4-Oxo-2-(1H-tetrazol-5-yl)-4H-1-benzopyran-8-yl)-p-(4-phenylbutoxy)benzamide;

UNII : TB8Z891092;

InChIKey : NBQKINXMPLXUET-UHFFFAOYSA-N;

CAS number : 103177-37-3;

Molecule name : ONO 1078; ONO-RS 411; RS 411; ONO-1078; SB 205312;

Chemical formula : C27H23N5O4;

Details

Origin ID

C96712;

UMLS CUI

C0526058;

CISMeF manual mappings
- Pranlukast (substance) [SNOMED CT concept]
Currated CISMeF NLP mapping
- pranlukast [MeSH concept]
- pranlukast [MeSH Supplementary Concept]
Semantic type(s)
- Organic Chemical [UMLS semantic type]
- Pharmacologic Substance [UMLS semantic type]
UMLS correspondences (same concept)
- Pranlukast (substance) [SNOMED CT concept]
- pranlukast [MeSH Supplementary Concept]
- pranlukast [ATC Code]
- pranlukast [MeSH concept]
Validated automatic mappings to BTNT
- pranlukast [ATC Code]
concept_is_in_subset
- FDA Established Names and Unique Ingredient Identifier Codes Terminology [NCIt concept]

Keyword's position in hierarchy(ies) :

You can consult :

recommendations
documents concerning education
documents for patients